Recurrent urinary tract infections and low secretory IgA following CD19-directed CAR T-cell therapy for relapsed acute lymphoblastic leukemia. [electronic resource]
Producer: 20190305ISSN:- 1545-5017
- Antigens, CD19 -- analysis
- Antimetabolites, Antineoplastic -- therapeutic use
- B-Lymphocytes -- immunology
- Bacteriuria
- Child
- Clofarabine -- therapeutic use
- Cytarabine -- therapeutic use
- Escherichia coli -- immunology
- Escherichia coli Infections -- immunology
- Female
- Humans
- Immunoglobulin A, Secretory -- blood
- Immunoglobulin G -- blood
- Immunoglobulin M -- blood
- Immunotherapy, Adoptive -- adverse effects
- Lymphocyte Count
- Neoplasm Recurrence, Local -- drug therapy
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Proteus Infections -- immunology
- Proteus mirabilis -- immunology
- Urinary Tract Infections -- immunology
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.